BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 30909929)

  • 21. An essential role of RNF187 in Notch1 mediated metastasis of hepatocellular carcinoma.
    Zhang L; Chen J; Yong J; Qiao L; Xu L; Liu C
    J Exp Clin Cancer Res; 2019 Sep; 38(1):384. PubMed ID: 31477177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PAK1 promotes proliferation, migration and invasion of hepatocellular carcinoma by facilitating EMT via directly up-regulating Snail.
    Cao F; Yin LX
    Genomics; 2020 Jan; 112(1):694-702. PubMed ID: 31071459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways.
    Huang Q; Zhan L; Cao H; Li J; Lyu Y; Guo X; Zhang J; Ji L; Ren T; An J; Liu B; Nie Y; Xing J
    Autophagy; 2016 Jun; 12(6):999-1014. PubMed ID: 27124102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
    Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
    Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.
    Xiao S; Chang RM; Yang MY; Lei X; Liu X; Gao WB; Xiao JL; Yang LY
    Hepatology; 2016 Apr; 63(4):1256-71. PubMed ID: 26698646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
    Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
    Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
    Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MXR7 facilitates liver cancer metastasis via epithelial-mesenchymal transition.
    Lv G; Tan Y; Lv H; Fang T; Wang C; Li T; Yu Y; Hu C; Wen W; Wang H; Yang W
    Sci China Life Sci; 2017 Nov; 60(11):1203-1213. PubMed ID: 28812296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KIAA1217 Promotes Epithelial-Mesenchymal Transition and Hepatocellular Carcinoma Metastasis by Interacting with and Activating STAT3.
    Wang Y; Li N; Zheng Y; Wang A; Yu C; Song Z; Wang S; Sun Y; Zheng L; Wang G; Liu L; Yi J; Huang Y; Zhang M; Bao Y; Sun L
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial fission forms a positive feedback loop with cytosolic calcium signaling pathway to promote autophagy in hepatocellular carcinoma cells.
    Huang Q; Cao H; Zhan L; Sun X; Wang G; Li J; Guo X; Ren T; Wang Z; Lyu Y; Liu B; An J; Xing J
    Cancer Lett; 2017 Sep; 403():108-118. PubMed ID: 28624623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling.
    Lv X; Yu H; Zhang Q; Huang Q; Hong X; Yu T; Lan H; Mei C; Zhang W; Luo H; Pang P; Shan H
    J Cell Mol Med; 2020 Sep; 24(18):10714-10729. PubMed ID: 32746503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.
    Fang F; Song T; Zhang T; Cui Y; Zhang G; Xiong Q
    Oncotarget; 2017 May; 8(19):31745-31757. PubMed ID: 28423650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.
    Lei X; Xu JF; Chang RM; Fang F; Zuo CH; Yang LY
    Oncotarget; 2016 Jun; 7(26):40266-40284. PubMed ID: 27259236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.
    Zhou SL; Zhou ZJ; Hu ZQ; Li X; Huang XW; Wang Z; Fan J; Dai Z; Zhou J
    Cancer Lett; 2015 Mar; 358(2):124-135. PubMed ID: 25462858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NAD(P)HX epimerase downregulation promotes tumor progression through ROS/HIF-1α signaling in hepatocellular carcinoma.
    Sun B; Yu L; Xu C; Li YM; Zhao YR; Cao MM; Yang LY
    Cancer Sci; 2021 Jul; 112(7):2753-2769. PubMed ID: 33932069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD24 promotes HCC progression via triggering Notch-related EMT and modulation of tumor microenvironment.
    Wan X; Cheng C; Shao Q; Lin Z; Lu S; Chen Y
    Tumour Biol; 2016 May; 37(5):6073-84. PubMed ID: 26608371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma.
    Ou H; Chen Z; Xiang L; Fang Y; Xu Y; Liu Q; Hu Z; Li X; Huang Y; Yang D
    Cancer Sci; 2019 Apr; 110(4):1169-1182. PubMed ID: 30677195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
    Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
    J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo.
    Lu HY; Chu HX; Tan YX; Qin XC; Liu MY; Li JD; Ren TS; Zhang YS; Zhao QC
    Life Sci; 2020 Mar; 244():117343. PubMed ID: 31978449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.